To answer the question whether FGFR3 somatic mutations can modulate DNA methylation in urothelial carcinomas, we thus decided to analyze the DNA methylation landscape of 20 bladder cancer cell lines. This evidence concerns the gene FGFR3 and urinary bladder carcinoma.